Cengild Medical Berhad Capital Reinvestment Ratio
Cengild Medical Berhad capital reinvestment ratio. Cengild Medical Berhad (0243) has a Capital Reinvestment Ratio of 2.61x as of June 2026, meaning it reinvests 3% of its operating cash flow (RM4.65 Million) in capital expenditures (RM12.15 Million). See how much free cash does Cengild Medical Berhad generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cengild Medical Berhad (2020–2026)
Capital reinvestment ratio of Cengild Medical Berhad from 2020 to 2026. This chart tracks Cengild Medical Berhad's Capital Reinvestment Ratio across 7 annual periods. See Cengild Medical Berhad (0243) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cengild Medical Berhad Capital Reinvestment Ratio by Year (2020–2026)
Cengild Medical Berhad capital reinvestment ratio by year from 2020 to 2026. For the full cash flow conversion analysis, see Cengild Medical Berhad (0243) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 6.21x | RM13.10 Million | RM81.35 Million | ▲ +167.9% |
| 2025 | 2.32x | RM16.08 Million | RM37.26 Million | ▲ +90.5% |
| 2024 | 1.22x | RM12.94 Million | RM15.73 Million | ▲ +686.2% |
| 2023 | 0.15x | RM13.76 Million | RM2.13 Million | ▲ +408.4% |
| 2022 | 0.03x | RM14.05 Million | RM427.67K | ▼ -74.4% |
| 2021 | 0.12x | RM14.30 Million | RM1.70 Million | ▲ +118.8% |
| 2020 | 0.05x | RM11.24 Million | RM610.08K | — |